| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |